OSE IMMUNOTHERAPEUTICS |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.19 EUR | +3.80% |
|
+10.19% | +21.26% |
| Apr. 17 | OSE: licensing agreement with AbbVie enters into force | CF |
| Apr. 17 | OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie | MT |
Quotes 5-day view
Real-time Euronext Paris| 2024-04-15 | 2024-04-16 | 2024-04-17 | 2024-04-18 | 2024-04-19 | |
|---|---|---|---|---|---|
| Last | 4.615 € | 4.65 € | 4.875 € | 5 € | 5.19 € |
| Volume | 46 010 | 51 090 | 248 766 | 128 837 | 122 937 |
| Change | -2.02% | +0.76% | +4.84% | +2.56% | +3.80% |
| Opening | 4.71 | 4.63 | 4.94 | 4.90 | 4.96 |
| High | 4.73 | 4.65 | 4.97 | 5.00 | 5.22 |
| Low | 4.61 | 4.51 | 4.68 | 4.77 | 4.95 |
Performance
| 1 day | +3.80% | ||
| 1 week | +10.19% | ||
| Current month | +6.79% | ||
| 1 month | +10.19% | ||
| 3 months | +39.33% | ||
| 6 months | +17.02% | ||
| Current year | +21.26% | ||
| 1 year | +6.03% | ||
| 3 years | -57.32% | ||
| 5 years | +29.75% |
Volumes
marketsDaily volume
122 937
Estimated daily volume
203 218
Avg. Volume 20 sessions
107 991
Daily volume ratio
1.88
Avg. Volume 20 sessions
560 473.29
Avg. Volume 20 sessions USD
597 072.20
Record volume 1
4 061 203
Record volume 2
3 484 387
Record volume 3
1 872 725
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (EUR)
107 949 320
Capitalization (USD)
114 998 411
Net sales (EUR)
2 227 000
Net sales (USD)
2 372 423
Number of employees
62
Sales / Employee (EUR)
35 919
Sales / Employee (USD)
38 265
Free-Float
72.4 %
Free-Float capitalization (EUR)
78 455 072
Free-Float capitalization (USD)
83 578 188
Average Daily Capital Traded
0.52%
Highs and lows
1 week
4.51
5.22
1 month
4.415.27
Current year
3.126.00
1 year
2.717.31
3 years
2.7113.68
5 years
2.7115.80
10 years
2.7015.80
Indicators
Moving average 5 days
4.77
Moving average 20 days
4.81
Moving average 50 days
4.44
Moving average 100 days
4.24
Price spread / (MMA5)
-8.09%
Price spread / (MMA20)
-7.32%
Price spread / (MMA50)
-14.41%
Price spread / (MMA100)
-18.34%
STIM
RSI 9 days
56.21
RSI 14 days
55.32
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +3.80% | +10.19% | +21.26% | +6.03% | 115M | ||
| -0.04% | -4.56% | -1.82% | +12.06% | 41.35B | ||
| -1.22% | -5.83% | +42.44% | -13.17% | 40.38B | ||
| -1.39% | -4.68% | +2.56% | -28.49% | 39.05B | ||
| +3.57% | -1.34% | -12.11% | +3.57% | 26.67B | ||
| -0.07% | -6.58% | +3.09% | +37.06% | 24.07B | ||
| -0.11% | -4.56% | -24.16% | -28.02% | 18.36B | ||
| -2.12% | -6.96% | +22.12% | +95.28% | 11.6B | ||
| -1.10% | -7.66% | -3.74% | +10.45% | 11.68B | ||
| +0.69% | -0.13% | +7.75% | +3.93% | 11.15B | ||
| -0.83% | -9.59% | -19.38% | -26.23% | 9.78B | ||
| +0.61% | -4.13% | -11.84% | -16.41% | 8.74B | ||
| -1.11% | -4.28% | +18.77% | -18.78% | 6.46B | ||
| -.--% | -.--% | - | - | 6.07B | ||
| -2.69% | -4.22% | +24.93% | +47.63% | 5.9B | ||
| -0.24% | -3.98% | -19.33% | +12.18% | 5.95B | ||
| Average | -0.15% | -4.01% | +3.37% | +6.47% | ||
| Weighted average by Cap. | -0.26% | -4.84% | +4.63% | +1.65% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
6f85a067.J830xKkB5CCBc7rsTMm3Li9xYu3R7TFe3Yhaz8QojAo.Raylgv40tFe2AeOGJ4vNexcFLdu8ukVz7cMZo4ty9m139bGmmFWzeNc14w
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 08:09:15 am | 5.19 | 212 | 122,937 |
| 08:09:15 am | 5.19 | 16 | 122,725 |
| 08:09:15 am | 5.19 | 128 | 122,709 |
| 08:07:11 am | 5.19 | 115 | 122,581 |
| 08:07:11 am | 5.19 | 15 | 122,466 |
| 08:07:09 am | 5.2 | 242 | 122,451 |
| 08:07:09 am | 5.2 | 1,500 | 122,209 |
| 08:07:09 am | 5.2 | 12 | 120,709 |
| 08:07:09 am | 5.2 | 30 | 120,697 |
| 08:07:09 am | 5.2 | 250 | 120,667 |
Monthly variations
Annual change
| 2024 | +16.82% | ||
| 2023 | -35.88% | ||
| 2022 | -35.07% | ||
| 2021 | +42.78% | ||
| 2020 | +94.59% | ||
| 2019 | +8.82% | ||
| 2018 | -11.69% | ||
| 2017 | -45.62% | ||
| 2016 | -16.41% | ||
| 2015 | -18.95% |
- Stock Market
- Equities
- OSE Stock
- Quotes OSE Immunotherapeutics
